key: cord-0703489-pquog4dp authors: Jha, Pranaw Kumar; Yadav, Dinesh Kumar; Siddini, Vishwanath; Bansal, Shyam Bihari; Sharma, Reetesh; Anandh, Urmila; Jeloka, Tarun; Reddy, Sreedhar; Pokhariyal, Saurabh; Nandwani, Ashish; Jain, Salil; Saxena, Vishal; Sethi, Sidharth Kumar; Bansal, Dinesh; Jain, Manish; Sodhi, Puneet; Gadde, Ashwini; Augustine, Rohan; Zafar, Feroz Amir; Ghosh, Prasun; Tiwari, Aseem Kumar; Ahlawat, Rajesh; Kher, Vijay title: A retrospective multi‐center experience of renal transplants from India during COVID‐19 pandemic date: 2021-07-19 journal: Clin Transplant DOI: 10.1111/ctr.14423 sha: 219379148d09e4f522834c7752719a9f58c5f413 doc_id: 703489 cord_uid: pquog4dp INTRODUCTION: Coronavirus disease 2019 (COVID‐19) pandemic led to a sudden drop in renal transplant numbers across India in the initial months of 2020. Although the transplant numbers increased with easing of lockdown, the outcome of these transplants remains unknown. METHODS: This was a retrospective, observational, multi‐center study done across eight different transplant centers in India. All the transplants done from January 30, 2020 to December 31, 2020 were included. The primary outcomes studied were patient and death censored graft survival as well as incidence of COVID‐19 infection and its outcomes. RESULTS: During the study period a total of 297 kidney transplants were done. After a median follow up of 265 days the patient and death censored graft survival was 95.3% and 97.6%, respectively. Forty‐one patients (13.8%) developed COVID‐19 post‐transplant. Majority (58.5%) were asymptomatic to mildly symptomatic and the case fatality ratio was 14.6%. On multivariable logistic regression analysis older age was associated with higher likelihood of COVID‐19 infection (odds ratio 1.038; CI 1.002–1.077). CONCLUSIONS: Patient and graft outcome of kidney transplants done during the COVID‐19 pandemic in India was acceptable. The incidence of COVID‐19 was 13.8% with a high case fatality ratio. This was a multi-center retrospective observational study. The study population consisted of end stage renal disease (ESRD) patients who got transplanted across eight different centers in the various cities of India (Table 1 ). The study period was from January 30, 2020 to December 31, 2020. Patients were followed up till May 31, 2020. The donor and recipient were worked up in detail including the immunological evaluation as per the center protocol. During the study period, a total of 297 renal transplants were done. Figure 5 shows the Kaplan Meier curve for COVID-19 free survival. Mechanical Ventilation(n (%)) 5 (12.2) Patient loss(n (%)) 6 (14.6) Death censored graft loss(n (%)) 2 (4.9) BPAR(n (%)) 6 (14.6) Abbreviations: CNI, calcineurin inhibitor; BPAR, biopsy proven acute rejection. 12 weeks depending upon the severity of symptoms. 16 Remdesivir has been shown to shorten the time to recovery in adults admitted with COVID-19 and having evidence of lower respiratory tract infection. 25 Although later the SOLIDARITY trial showed little or no effect of this treatment in hospitalized COVID-19 patients. 26 On a multivariable logistic regression analysis older age was the only factor associated with significantly higher likelihood of developing COVID-19 infection in the present study. Increasing age has been associated with higher incidence of SARS-CoV-2 infection in solid organ transplant recipients in other study as well. 21 Patients contracting COVID-19 were noted to have higher mortality risk in our study. The present study shows the feasibility and safety of renal transplant done during the COVID-19 pandemic in India with acceptable outcomes. The alteration in induction strategy was not necessary. The recipients as well as donor who contracted COVID-19 in pretransplant period could safely proceed with the surgery after the necessary waiting time. The rate of contracting COVID-19 in recipients was 13.8%. As has been described in previous studies, the mortality in patients getting COVID was high at 14.6%. There are few limitations of our study. It is a retrospective study. As We thank all the members of the transplant team involved in the care of transplant patients. The data that support the findings of this study are available on request from the corresponding author (Pranaw Kumar Jha; dr.pranaw@gmail.com). The data are not publicly available due to privacy or ethical restrictions. Pranaw Kumar Jha https://orcid.org/0000-0003-1612-9215 Shyam Bihari Bansal https://orcid.org/0000-0002-8665-8588 Urmila Anandh https://orcid.org/0000-0003-3298-8642 COVID-19) Dashboard Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a regionwide registry study COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration Status of SARS-CoV-2 infection in patients on renal replacement therapy Clinical profile and outcome of COVID-19 in 250 kidney transplant recipients: a multicenter cohort study from India Covid-19 and Kidney Transplantation COVID-19 in solid organ transplant recipients: initial report from the US epicenter COVID-19 and kidney transplantation: an Italian survey and consensus Kidney transplant programmes during the COVID-19 pandemic Current trends in kidney transplantation in India Paired kidney exchange transplantation: maximizing the donor pool ABO-incompatible renal transplantation in developing world -crossing the immunological (and mental) barrier Impact of single centre kidney paired donation transplantation to increase donor pool in India: a cohort study Kidney transplantation using lymphocyte depleting induction and standard maintenance immunosuppression at the height of the SARS-CoV-2 pandemic Statement on Elective Surgery and Anesthesia for Patients after COVID-19 Infection COVID 19 rapid guideline: renal transplantation Successful kidney transplantation after COVID-19 infection in two cases Is it safe to be transplanted from living donors who recovered from COVID-19? Experience of 31 kidney transplants in a multicenter cohort study from India Summary of international recommendations for donation and transplantation programs during the coronavirus disease pandemic SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: a national cohort study Systematic review and metaanalysis of COVID-19 and kidney transplant recipients, the South West London Kidney Transplant Network Experience COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes Dexamethasone in hospitalized patients with Covid-19 Remdesivir for the treatment of Covid-19 -final report Repurposed antiviral drugs for COVID-19 -interim WHO solidarity trial results A systematic review of COVID-19 and kidney transplantation COVID-19 after kidney transplantation: early outcomes and renal function following antiviral treatment A Retrospective Multi-Center Experience of Renal Transplants from India During COVID-19 Pandemic